AdvaMed Urges Congress to Avert Shutdown, Protect Patients
WASHINGTON – Today, AdvaMed, the Medtech Association, called on congressional leaders to work together to prevent a federal government shutdown.
“A shutdown of any length could seriously impact patients, as FDA, CMS, and other federal agencies related to our healthcare system will have to stop their work on the life-improving and live-saving medical technologies that so many patients across the country depend on,” said Scott Whitaker, AdvaMed President and CEO. “This will have a cascading effect on medtech innovators who are already struggling as they await FDA and CMS decisions on their medical technologies, treatments, and diagnostics. We urge Congress and the President to come together and fund the federal government and prevent a shutdown that could impact millions of patients nationwide.”
###
Related Reading
News / Government & Legislative Affairs
AdvaMed Urges Senate Leader to Prioritize R&D Tax Credit in Any Tax Package
April 17, 2024
This week, in a letter to Senate Majority Leader Chuck Schumer, AdvaMed President and CEO Scott Whitaker underscored the critical importance of passing a tax provision that allows small businesses to deduct their research and development expenses in the year the expense was incurred. AdvaMed, the world’s largest trade association representing medical technology companies, supports the provision, which until 2022, encouraged small companies and startups to continue investing in R&D, the lifeblood of these primarily pre-commercial companies.
News / Diagnostics / Government & Legislative Affairs / VALID Act
In Congressional Testimony, AdvaMed Urges Passage of Diagnostic Regulatory Reform
March 21, 2024
Today, Zach Rothstein, Executive Director of AdvaMedDx, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed test (LDT) rule.
Blog / Government & Legislative Affairs
“Transparency, Inclusion, and Example”: How to Lead in Congress, Business, or Anywhere, According to Former U.S. Senator Richard Burr
March 6, 2024
Former U.S. Senator Richard Burr of North Carolina joined me on the Medtech POV podcast to share his perspective on policy and leadership. Having served in the U.S. House and Senate for nearly three decades, including tenure as Ranking Member of the Senate Committee on Health, Education, Labor and Pensions (HELP), he’s an expert on health care policy. He also has a historical perspective that anyone involved in health-care policy should value.
News / Government & Legislative Affairs
In Letter, AdvaMed CEO Calls on CMS to Release Final Breakthrough Technology Coverage Rule, Calling Delay “Puzzling”
February 29, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, sent a letter to CMS Administrator Chiquita Brooks-LaSure outlining industry disappointment in the lack of a finalized rule for Transitional Coverage for Emerging Technology.
News / Government & Legislative Affairs
AdvaMed Calls on Congress to Prevent Government Shutdown
February 26, 2024
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
News / Government & Legislative Affairs / VALID Act
New Episode of Medtech POV Podcast: Senator Richard Burr Discusses AI and Health Care, the VALID Act
February 20, 2024
Today, AdvaMed, the Medtech Association, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.
News / Ethylene Oxide / Government & Legislative Affairs
Heart Surgeon, Small Medtech Company Leader Urges “Sensible” Sterilization Regulations, Cites Dire Consequences for Patients
February 14, 2024
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and medtech innovation if proposals further regulating the most prevalent method of sterilizing medical technology go forward without significant changes.
News / Government & Legislative Affairs
AdvaMed Announces New Chair of State Medtech Alliance
February 6, 2024
Today, AdvaMed, the Medtech Association, announced Kelvyn Cullimore, President and CEO of BioUtah, will serve as the next chair of the State Medtech Alliance (SMTA). The Alliance is a consortium of state and regional trade associations representing their local medical technology companies. Cullimore succeeds Dean Paranicas, who previously served as President and CEO of the HealthCare Institute of New Jersey (HINJ).